| |
| |
|
| Insider
Information: |
Scherle Peggy |
| Relationship: |
Chief Scientific Officer |
| City: |
Wilmington |
| State: |
DE |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
172,920 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
172,920 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Prelude Therapeutics Inc |
PRLD |
Chief Scientific Officer |
2021-08-27 |
172,920 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PRLD |
Prelude Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-08-27 |
4 |
AS |
$35.32 |
$215,967 |
D/D |
(6,014) |
172,920 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-08-27 |
4 |
OE |
$1.43 |
$8,600 |
D/D |
6,014 |
178,934 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-08-26 |
4 |
AS |
$35.19 |
$59,819 |
D/D |
(1,700) |
172,920 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-08-26 |
4 |
OE |
$1.43 |
$2,431 |
D/D |
1,700 |
174,620 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-08-13 |
4 |
AS |
$35.07 |
$80,161 |
D/D |
(2,286) |
172,920 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-08-13 |
4 |
OE |
$1.43 |
$3,526 |
D/D |
2,286 |
175,206 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-07-27 |
4 |
AS |
$35.45 |
$709,380 |
D/D |
(20,000) |
172,920 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-07-27 |
4 |
OE |
$1.43 |
$28,600 |
D/D |
20,000 |
192,920 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-05-07 |
4 |
AS |
$40.30 |
$408,192 |
D/D |
(10,000) |
172,920 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-05-07 |
4 |
OE |
$1.43 |
$14,300 |
D/D |
10,000 |
182,920 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-04-08 |
4 |
AS |
$36.97 |
$177,504 |
D/D |
(4,630) |
172,920 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-04-08 |
4 |
A |
$1.43 |
$6,621 |
D/D |
4,630 |
177,550 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-04-07 |
4 |
AS |
$39.02 |
$604,144 |
D/D |
(15,370) |
172,920 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-04-07 |
4 |
A |
$1.43 |
$21,979 |
D/D |
15,370 |
188,290 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Scientific OfficerOffice |
• – – |
2020-09-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
172,920 |
|
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
